Skip to main content

October 2017 Vol 10, No 7

Original Research, Practice Management
The Cost of Hematopoietic Stem-Cell Transplantation in the United States
Michael S. Broder, MD, MSHS; Tiffany P. Quock, PhD, MS; Eunice Chang, PhD; Sheila R. Reddy, PhD, RPh; Rajni Agarwal-Hashmi, MD; Sally Arai, MD; Kathleen F. Villa, MS
Stakeholder Perspective
More Data Analysis Is Needed to Improve Outcomes, Lower Costs, and Maximize Appropriate Resource Use
James T. Kenney, RPh, MBA
Read More
Perspectives
Trending BIO
David B. Nash, MD, MBA
Read More
Original Research, Practice Management
Economic Impact of Increased Utilization of Multivariate Assay Testing to Guide the Treatment of Ovarian Cancer: Implications for Payers
Burton S. Brodsky, MD; Gary M. Owens, MD; Dennis J. Scotti, PhD, MBA; Keith A. Needham, BS; Christina L. Cool, MPH
Stakeholder Perspective
Economic Impact of Using Tests to Guide the Treatment of Patients with Ovarian Cancer
F. Randy Vogenberg, PhD, RPh
Read More

Results 1 - 3 of 3